Literature DB >> 17530170

Histone deacetylases: focus on the nervous system.

B E Morrison1, N Majdzadeh, S R D'Mello.   

Abstract

Neurodegenerative disease strikes millions worldwide and there is mounting evidence suggesting that underlying the onset and progression of these debilitating diseases is inappropriate neuronal apoptosis. Recent reports have implicated a family of proteins known as histone deacetylases (HDACs) in various neuronal processes including the neuronal death program. Initial headway in this field has been made largely through the use of broad-spectrum HDAC inhibitors. In fact, pharmacological inhibition of HDAC activity has been shown to protect neurons in several models of neurodegeneration. The observation that HDAC inhibitors can have opposing effects in different paradigms of neurodegeneration suggests that individual members of the HDAC protein family may play distinct roles that could depend on the specific cell type under study. The purpose of this review is to detail work involving the use of HDAC inhibitors within the context of neurodegeneration and examine the roles of individual HDAC members in the nervous system with specific focus on neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530170     DOI: 10.1007/s00018-007-7035-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  33 in total

1.  Prediction of human protein-protein interaction by a mixed Bayesian model and its application to exploring underlying cancer-related pathway crosstalk.

Authors:  Yan Xu; Wen Hu; Zhiqiang Chang; Huizi Duanmu; Shanzhen Zhang; Zhenqi Li; Zihui Li; Lili Yu; Xia Li
Journal:  J R Soc Interface       Date:  2010-10-13       Impact factor: 4.118

2.  Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.

Authors:  Haiqun Jia; Judit Pallos; Vincent Jacques; Alice Lau; Bin Tang; Andrew Cooper; Adeela Syed; Judith Purcell; Yi Chen; Shefali Sharma; Gavin R Sangrey; Shayna B Darnell; Heather Plasterer; Ghazaleh Sadri-Vakili; Joel M Gottesfeld; Leslie M Thompson; James R Rusche; J Lawrence Marsh; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

Review 3.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

4.  Conditional deletion of histone deacetylase-4 in the central nervous system has no major effect on brain architecture or neuronal viability.

Authors:  Valerie Price; Lulu Wang; Santosh R D'Mello
Journal:  J Neurosci Res       Date:  2012-12-14       Impact factor: 4.164

Review 5.  RNA-binding proteins associated molecular mechanisms of motor neuron degeneration pathogenesis.

Authors:  Anna Y Tang
Journal:  Mol Biotechnol       Date:  2014-09       Impact factor: 2.695

Review 6.  Selective class IIa HDAC inhibitors: myth or reality.

Authors:  Eros Di Giorgio; Enrico Gagliostro; Claudio Brancolini
Journal:  Cell Mol Life Sci       Date:  2014-09-05       Impact factor: 9.261

7.  Trichostatin A and Sirtinol Regulate the Expression and Nucleocytoplasmic Shuttling of Histone Deacetylases in All-Trans Retinoic Acid-Induced Differentiation of Neuroblastoma Cells.

Authors:  Bong-Geum Jang; Boyoung Choi; Suyeon Kim; Jae-Yong Lee; Min-Ju Kim
Journal:  J Mol Neurosci       Date:  2018-03-07       Impact factor: 3.444

Review 8.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

9.  Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.

Authors:  Nikolai D Belyaev; Natalia N Nalivaeva; Natalia Z Makova; Anthony J Turner
Journal:  EMBO Rep       Date:  2008-12-05       Impact factor: 8.807

10.  Molecular and pathologic insights from latent HIV-1 infection in the human brain.

Authors:  Paula Desplats; Wilmar Dumaop; David Smith; Anthony Adame; Ian Everall; Scott Letendre; Ronald Ellis; Mariana Cherner; Igor Grant; Eliezer Masliah
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.